Researchers from the University of Bonn have isolated a molecule that is suitable for the control of contact allergies. The study illuminates a central immune mechanism, which may also play a role in other inflammatory diseases such as arthritis or arteriosclerosis. The results will soon be published in the journal Molecular Therapy, but are already available online.
The newly discovered substance is a so-called RNA aptamer. Aptamers are molecules that are related to DNA, the carrier of the genetic information in our cells. They can specifically bind to unique target structures of proteins and thereby block them.
"Our aptamer interferes with the communication between two important types of immune cells - T cells and dendritic cells," says Prof. Dr. Irmgard Förster, who heads the department of "Immunology and Environment" at the LIMES Institute of the University of Bonn. She is also a member of the Excellence Cluster "ImmunoSensation", a major center of immunological research in Germany.
Allergies occur when immune responses react in an uncontrolled way against otherwise harmless substances from the environment. Among other culprits, T-cells are responsible for the resulting damage. These guardians of the immune system normally kill diseased cells, such as those infected by a virus.
Patrolling T cells are activated by so-called dendritic cells, which are distributed throughout the body and sense signs of an infection or tissue damage. If they find something suspicious, they alert the killer troops by releasing certain chemoattractant proteins (chemokines) that resemble odorants. In humans there are about 50 different types of these signaling substances. One of them is CCL17. T cells have a receptor that can "smell" CCL17 - the CCR4 receptor - which allows them to follow the signal to its source.
"We have succeeded in producing an aptamer that specifically binds to CCL17," explains Prof. Förster. "It thus prevents CCL17 from docking to the CCR4 receptor. This way, we were able to partly block the migration of T cells to the dendritic cells. Mice treated with the aptamer therefore showed a far weaker inflammatory response to a contact allergen. "
Two chemokines stimulate the same receptor
It is known that the binding of CCL17 to the CCR4 receptor plays an important role in allergies. Other research groups have already tried to inhibit the CCR4 receptor (the "nose" of the T cells). Surprisingly, this strategy had no success - on the contrary: the allergic reaction was even more pronounced in tests. This may be associated with a specific property of the receptor: It can also be activated by at least one other chemokine - CCL22. CCL22 seems to have a different effect on CCR4 than CCL17. Researchers speculate that CCL22 (or possibly also other chemokines) inhibits the immune reaction – and does not stimulate it like CCL17. If the receptor is completely blocked, the allergic reaction can therefore even increase.
"Using aptamers, such mechanisms can be explored much more precisely," says Prof. Dr. Günter Mayer, a chemist who led the study together with Prof. Förster. Mayer heads the Center for Aptamer Research and Development at the LIMES Institute. "At present, we are able to produce aptamers comparatively simple and fast, with an astounding specificity for certain target structures," he says. The current aptamer is a good example: In even the smallest amounts it efficiently neutralizes CCL17, while completely ignoring CCL22.
The study highlights the importance of the chemokine-dependent communication between T cells and dendritic cells in the context of allergy, and potentially also in autoimmune disorders such as rheumatism or atherosclerosis. The researchers now aim to develop a similar aptamer against human CCL17 to be able to translate their findings from the animal model to clinical application.
Dr. Andreas Archut | idw - Informationsdienst Wissenschaft
How Helicobacter pylori causes gastric cancer
07.11.2017 | Friedrich-Alexander-Universität Erlangen-Nürnberg
Colorectal cancer screening should start at 45, new research shows
30.10.2017 | Spink Health
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.
Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...
Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...
The Fraunhofer Institute for Laser Technology ILT and Rapid Shape GmbH are working together to further develop resin-based 3D printing. The new “TwoCure” process requires no support structures and is significantly more efficient and productive than conventional 3D printing techniques for plastic components. Experts from Fraunhofer ILT will be presenting the state-funded joint development that makes use of the interaction of light and cold in forming the components at formnext 2017 from November 14 to 17 in Frankfurt am Main.
Much like stereolithography, one of the best-known processes for printing 3D plastic components works using photolithographic light exposure that causes liquid...
A team of researchers led by Prof. Wolfram Pernice from the Institute of Physics at Münster University has developed a miniature abacus on a microchip which calculates using light signals. With it they are paving the way to the development of new types of computer in which, as in the human brain, the computing and storage functions are combined in one element.
Researchers at the universities of Münster, Exeter and Oxford have developed a miniature “abacus” which can be used for calculating with light signals. With it...
30.10.2017 | Event News
23.10.2017 | Event News
17.10.2017 | Event News
07.11.2017 | Materials Sciences
07.11.2017 | Life Sciences
07.11.2017 | Ecology, The Environment and Conservation